Lipoprotein(a) concentration shows little relationship to IDDM complications in the Pittsburgh Epidemiology of Diabetes Complications Study cohort
- PMID: 8495616
- DOI: 10.2337/diacare.16.5.755
Lipoprotein(a) concentration shows little relationship to IDDM complications in the Pittsburgh Epidemiology of Diabetes Complications Study cohort
Abstract
Objective: To examine the potential associations of lipoprotein(a) and the complications of IDDM and their risk factors.
Research design and methods: This report focuses on 186 individuals with IDDM (mean age = 34 yr) participating in a 10-yr prospective study examining various complications. Lp(a) concentrations were evaluated for those with and without complications.
Results: A weak correlation was seen between Lp(a) and HbA1 (r = 0.16, P < 0.05). Lp(a) concentrations were not significantly different for those with or without proliferative retinopathy, overt nephropathy, peripheral vascular disease, or definite myocardial infarction or angina. However, an inverse association (P < 0.05) was seen with distal symmetric polyneuropathy. These results were also confirmed by categorical analyses (i.e., Lp(a) levels < or = 30 vs. > 30 mg/dl).
Conclusions: These results suggest that any association of Lp(a) concentration with IDDM complications is likely to be weak or nonexistent. However, prospective studies are needed before its full role can be determined.
Similar articles
-
Spontaneous whole blood platelet aggregation, hematological variables and complications in insulin-dependent diabetes mellitus: the Pittsburgh Epidemiology of Diabetes Complications Study.J Diabetes Complications. 1992 Jan-Mar;6(1):12-8. doi: 10.1016/1056-8727(92)90043-k. J Diabetes Complications. 1992. PMID: 1562753
-
Factors associated with avoidance of severe complications after 25 yr of IDDM. Pittsburgh Epidemiology of Diabetes Complications Study I.Diabetes Care. 1990 Jul;13(7):741-7. doi: 10.2337/diacare.13.7.741. Diabetes Care. 1990. PMID: 2387194
-
Incidence of complications in insulin-dependent diabetes mellitus: a survival analysis.Am J Epidemiol. 1996 Mar 1;143(5):431-41. doi: 10.1093/oxfordjournals.aje.a008763. Am J Epidemiol. 1996. PMID: 8610658
-
Blood glucose control and diabetic microvascular complications: long-term effects of near-normoglycaemia.Diabet Med. 1992 Oct;9(8):697-705. doi: 10.1111/j.1464-5491.1992.tb01876.x. Diabet Med. 1992. PMID: 1395460 Review. No abstract available.
-
Lessons from the Diabetes Control and Complications Trial.Diabetes. 1993 Nov;42(11):1549-54. doi: 10.2337/diab.42.11.1549. Diabetes. 1993. PMID: 8405693 Review. No abstract available.
Cited by
-
A prospective study of lipoprotein(a) and risk of coronary heart disease among women with type 2 diabetes.Diabetologia. 2005 Aug;48(8):1469-76. doi: 10.1007/s00125-005-1814-3. Epub 2005 Jun 22. Diabetologia. 2005. PMID: 15971061
-
Serum lipoprotein (a) in type 1 diabetic children and adolescents: relationships with HbA1c and subclinical complications.Eur J Pediatr. 1996 Mar;155(3):175-8. doi: 10.1007/BF01953933. Eur J Pediatr. 1996. PMID: 8929723
-
Lipoprotein (a) in the Development and Progression of Diabetic Retinopathy: A Systematic Review and Meta-Analysis.Medicina (Kaunas). 2025 Jun 24;61(7):1137. doi: 10.3390/medicina61071137. Medicina (Kaunas). 2025. PMID: 40731767 Free PMC article. Review.
-
Lipoprotein(a) and cardiovascular disease in diabetic patients.Clin Lipidol. 2012 Aug;7(4):397-407. doi: 10.2217/clp.12.46. Clin Lipidol. 2012. PMID: 23136583 Free PMC article.
-
Levels of lipoprotein(a), apolipoprotein B, and lipoprotein cholesterol distribution in IDDM. Results from follow-up in the Diabetes Control and Complications Trial.Diabetes. 1995 Oct;44(10):1218-26. doi: 10.2337/diab.44.10.1218. Diabetes. 1995. PMID: 7556961 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous